Department of Anesthesiology, General Hospital of Chengdu Military Command, Chengdu 610083, Sichuan Province, PR China.
Brain Res. 2013 Jun 23;1517:150-60. doi: 10.1016/j.brainres.2013.04.007. Epub 2013 Apr 17.
Hydrogen-rich saline (HS) is reported to be a new therapeutic agent in ischemia-reperfusion (I/R)-induced organ damage. The present study was designed to investigate the beneficial effects of HS against spinal cord I/R injury and its associated mechanisms. Spinal cord ischemia was induced by infrarenal aortic occlusion for 20min in male New Zealand white rabbits. Different doses of HS were intravenously (i.v.) administered at 5min before or after the beginning of reperfusion. Moreover, the roles of mitochondrial ATP-sensitive potassium channels (mitoKATP), oxidative stress, inflammatory cytokines and apoptosis was assessed. Here, we found that I/R-challenged rabbits exhibited significant spinal cord injury characterized by the decreased numbers of normal motor neurons and hind-limb motor dysfunction, which was significantly ameliorated by 5mL/kg and 10mL/kg HS treatment before reperfusion or 10mL/kg HS treatment after reperfusion. However, the protective effects of HS treatment in spinal cord I/R injury were partially abolished by the selective mitoKATP channel blocker 5-hydroxydecanoate (5-HD). Moreover, we showed that the beneficial effects of 10mL/kg HS treatment against spinal cord I/R damage were associated with the decreased levels of oxidative products [8-iso-prostaglandin F2α (8-iso-PGF2α) and malondialdehyde (MDA)] and pro-inflammatory cytokines [tumor necrosis factor-alpha (TNF-α) and high-mobility group box 1 (HMGB1)], as well as the increased activities of antioxidant enzymes [superoxide dismutase (SOD) and catalase (CAT)] in serum at 6h, 12h, 24h, 48h and 72h after reperfusion and in spinal cord at 72h after reperfusion. Furthermore, HS treatment (10mL/kg) reduced caspase-3 activity in the spinal cord of this model. Thus, HS may be an effective therapeutic agent for spinal cord I/R injury via activation of mitoKATP channels as well as reduction of oxidative stress, inflammatory cytokines and apoptosis.
富氢盐水(HS)被报道为一种缺血再灌注(I/R)诱导的器官损伤的新型治疗剂。本研究旨在探讨 HS 对脊髓 I/R 损伤的有益作用及其相关机制。雄性新西兰白兔通过肾下主动脉闭塞 20min 诱导脊髓缺血。HS 以不同剂量在再灌注开始前 5min 或再灌注后开始静脉(i.v.)给药。此外,还评估了线粒体 ATP 敏感性钾通道(mitoKATP)、氧化应激、炎症细胞因子和细胞凋亡的作用。结果发现,I/R challenged 兔表现出明显的脊髓损伤,其特征为正常运动神经元数量减少和后肢运动功能障碍,再灌注前给予 5mL/kg 和 10mL/kg HS 或再灌注后给予 10mL/kg HS 治疗可显著改善这种损伤。然而,选择性 mitoKATP 通道阻滞剂 5-羟基癸酸(5-HD)部分消除了 HS 处理对脊髓 I/R 损伤的保护作用。此外,我们还表明,10mL/kg HS 处理对脊髓 I/R 损伤的有益作用与氧化产物(8-异前列腺素 F2α(8-iso-PGF2α)和丙二醛(MDA))和促炎细胞因子(肿瘤坏死因子-α(TNF-α)和高迁移率族蛋白 1(HMGB1))水平降低以及血清中抗氧化酶(超氧化物歧化酶(SOD)和过氧化氢酶(CAT))活性升高有关,再灌注后 6h、12h、24h、48h 和 72h 以及再灌注后 72h 脊髓中。此外,HS 处理(10mL/kg)降低了该模型脊髓中 caspase-3 的活性。因此,HS 可能通过激活 mitoKATP 通道以及减少氧化应激、炎症细胞因子和细胞凋亡,成为一种有效的脊髓 I/R 损伤治疗剂。
Eur J Vasc Endovasc Surg. 2004-10
J Neurosurg Spine. 2014-1-24
J Thorac Cardiovasc Surg. 2012-12-13
Ann Vasc Surg. 2008
J Nanobiotechnology. 2024-5-23
Drug Des Devel Ther. 2024
Neurosci Bull. 2021-3
J Bioenerg Biomembr. 2019-11-25
Med Gas Res. 2019-1-9